Table 2

Immunophenotyping results

Cell subset (gating strategy), count/mm3 Discovery (n=203)Validation (n=144)
SSc (n=64)Ctrl (n=139)qSSc (n=72)Ctrl (n=72)q
Basophils (CD123 HLA-DR−)58.3±39.7184.9±464.60.00944.3±30.6**56±60.1*0.211
Eosinophils (CD15+ CD16−)174.5±371.1167.3±174.8NS146.6±86.6152.6±95NS
Neutrophils (CD15− CD16+)4116±23894363.3±2544.1NS4270±1648.83312.9±1324.3**0.001
LDGs (CD15hi CD14−)0±0.10±0.2NS0±0.10±0.1NS
Classical monocytes (CD14hi CD16−)376.9±170.3390.4±220.8NS342.8±168.8308.8±123.5**0.208
Intermediate monocytes (CD14+/hi CD16+)52.2±34.850.9±36.2NS65.3±37.2**48.4±24.80.004
Non classical monocytes (CD14+ CD16 hi)12.3±12.19.8±7.10.07110.3±7.68.2±6.30.09
NK regulatory (CD3− CD56hi CD16−)7±6.410±7.50.0024±3.6***6.8±4.6***0.004
NK cytotoxic (CD3− CD56lo CD16hi)132.7±95.3234.2±200.91.18E-05112.4±69.6190.3±121.30.002
NK-like T cells (CD3+ CD56+)65.7±54.9130.9±119.31.18E-0550.4±74.3**101.7±85.1**8.45E-05
B cells (CD3− CD19+)152±109.9256.3±217.61.43E-05169.2±136.2191.7±116.6**0.212
CD4 T cells (CD3+ CD4+ CD8−)649.9±284.31084.9±893.41.18E-05607±316760.8±329.7**0.043
CD8 T cells (CD3+ CD4 CD8+)258.6±144.8408.9±2792.11E-05226.8±154.2304.5±192.2**0.044
Double positive T cells (CD3+ CD8+ CD4+)11.4±9.523.1±23.15.76E-0514.5±20.817.9±17.80.16
Double negative T cells (CD3+ CD8- CD4−)20.7±1442±33.71.11E-0622.7±42.625±20.6***0.185
mDC1 (Lin-HLA-DR+ CD11c+ CD123 lo CD141− CD1c+)2.6±311.3±37.80.0051.2±1.1**3±6.7**8.12E-04
mDC2 (Lin-HLA-DR+ CD11c+ CD123 lo CD141+ CD1c−)60.1±90.8156±514.60.04644.7±45.939.3±37.6**NS
mDC (Lin-HLA-DR+ CD11c +CD123 lo CD141− CD1c)17.1±17.232.1±137.40.3537.7±8.7*10.9±29.9**NS
pDC (Lin-HLA-DR+ CD11c+ CD123 lo CD11c− CD123hi)10.2±9.255.1±174.28.22E-044.8±4.9*11.2±22.8***2.9E-05
  • False-discovery rate (FDR) corrected p values (q) after cube root transformation to unskew the data.

  • *q<0.05 versus discovery; **q<0.01 versus discovery; ***q<0.001 versus discovery.

  • DC, dendritic cells; LDG, low density grains; NK, natural killers.